指南与共识血栓与止血

新生儿血小板输注:新证据及将循证推荐转化为临床实践的挑战

Neonatal platelet transfusions: New evidence and the challenges of translating evidence-based recommendations into clinical practice.
指南 / 共识 · J Thromb Haemost · 2022-02-16

本文综述新生儿血小板输注的随机试验证据,指出三项新生儿随机试验提示伤害信号,其中最大试验纳入660名婴儿,随机分组后28天内死亡或大出血发生率显著更高,总体研究显示血小板输注降低出血风险的效果有限,并讨论将研究结果转化为实践的障碍及潜在机制。

要点

  • 三项新生儿随机试验提示血小板输注存在伤害信号,最大试验纳入660名婴儿。
  • 该最大试验中,随机分组后28天内死亡或大出血发生率显著更高。
  • 总体研究显示血小板输注降低出血风险的效果有限。

核心结论

  • 新生儿随机试验提示血小板输注存在伤害信号,总体研究显示其降低出血风险的效果有限。
  • 将试验结果转化为新生儿临床实践仍不一致,需确定具有成本效益的实施策略。

研究设计与样本

  • 本文为综述,汇总成人血液恶性肿瘤随机试验及三项患病新生儿随机试验的证据。

主要发现

  • 最大新生儿随机试验纳入660名婴儿,随机分组后28天内死亡或大出血发生率显著更高。
  • 总体研究显示血小板输注降低出血风险的效果有限。
  • 研究探索血小板输注无效及出血和死亡率增加的可能机制,包括血小板在脑发育脆弱期促进过度血管生成信号的作用。
  • 另一假设探索将「成人」血小板输注至「新生儿」血小板减少血液中对初级止血和免疫反应的影响。

临床怎么用

  • 作者指出有必要确定哪些实施策略(如审计与反馈、输血医嘱自动提醒系统、意见领袖)能(成本)有效地促成改变。

局限性

  • 仅三项随机试验在患病新生儿中开展。
  • 将研究结果纳入新生儿医学的 uptake 仍不一致。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Platelet transfusions are a common intervention for thrombocytopenia. Although the main reason for transfusing platelets is to improve hemostasis, platelets have many additional physiological roles, including interactions with immune pathways. Much of the evidence base for safe and effective transfusions has been informed by randomized trials in adult patients with hematological malignancies. Only three randomized trials have been conducted in sick neonates. These trials have indicated evidence of harm, including a significantly higher rate of death or major bleeding within 28 days after randomization for the largest trial, which enrolled 660 infants. The overall research indicates limited effectiveness of platelet transfusions to reduce bleeding risk. It is important that the results of trials are implemented into practice, but uptake of research findings into neonatal medicine remains inconsistent, as for many areas of health care. There is a need to establish which potential implementation strategies (cost-) efficiently enact change, such as audit and feedback, automated reminder systems for ordering transfusions, and use of opinion leaders. Research is exploring potential mechanisms underlying the lack of effectiveness of platelet transfusions and the increased bleeding and mortality observed in neonatal randomized trials. One potential mechanism concerns the roles of platelets to promote excessive angiogenic signals during a vulnerable period of brain development. A further hypothesis explores the effects of transfusing "adult" platelets into "neonatal" thrombocytopenic blood on primary hemostasis and immune responses.

来源:J Thromb Haemost,查看原文。版权归原作者所有。

引用

  1. Sola-Visner M, Leeman KT, Stanworth SJ, et al. Neonatal platelet transfusions: New evidence and the challenges of translating evidence-based recommendations into clinical practice. J Thromb Haemost. 2022. PMID: 35112471. doi:10.1111/jth.15664

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。